Assessment of the Embolization of Neurovascular Lesions Using the Penumbra Smart Coil

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 995 participants.

Also called NCT02729740

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 995 participants (enrolled count) (from the registry)
Sponsor
  • Penumbra Inc. Registry lists this organization as the lead sponsor
Registry
  • NCT NCT02729740
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02729740. Allocation not applicable; no masking; primary purpose treatment. Start 2016-06-03 (actual); primary completion 2019-12-27 (actual). Results posted on 2021-03-01.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Assessment of the Embolization of Neurovascular Lesions Using the Penumbra Smart Coil
Acronym
SMART
Condition
Intracranial Aneurysm
Intervention (Device)
Penumbra Smart Coil
Intervention (Device)
Penumbra Coil 400TM (PC400), Penumbra Occlusion DeviceTM(POD)
Lead sponsor
Penumbra Inc. (class: industry)

Record details

Record id
cardio:ct-nct02729740
Content hash
aa3e4e2d94e5e6ca29b612d8d1121644c60d09efb53e96329428cc3407f30348